Lymphoma (Hodgkin's Disease and
Non-Hodgkin's Lymphoma)

15 Cancer Symptoms Women Ignore Slideshow Pictures 15 Cancer Symptoms Men Ignore Slideshow Pictures Top Cancer-Fighting Foods Slideshow Pictures

Medical Author:

Jerry R. Balentine, DO, FACEP

Jerry R. Balentine, DO, FACEP

Dr. Balentine received his undergraduate degree from McDaniel College in Westminster, Maryland. He attended medical school at the Philadelphia College of Osteopathic Medicine graduating in1983. He completed his internship at St. Joseph's Hospital in Philadelphia and his Emergency Medicine residency at Lincoln Medical and Mental Health Center in the Bronx, where he served as chief resident.

View Full Profile

Medical Editor:

Melissa Conrad Stöppler, MD, Chief Medical Editor

Melissa Conrad Stöppler, MD, Chief Medical Editor

Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.

View Full Profile

• Lymphoma (Hodgkin's Disease and Non-Hodgkin's Lymphoma) Overview
• Lymphoma Causes
• Lymphoma Symptoms and Signs
• When to Seek Medical Care
• Lymphoma Diagnosis
• Lymphoma Treatment
• Medical Treatment
• Lymphoma Medications
• Other Therapy
• Follow-up
• Lymphoma Prevention
• Lymphoma Prognosis
• Support Groups and Counseling for Lymphoma
• For More Information on Lymphoma
• Web Links
• Synonyms and Keywords
• Authors and Editors
• Pictures of 15 Cancer Symptoms Women Ignore - Slideshow
• Pictures of 15 Cancer Symptoms Men Ignore - Slideshow
• Pictures of Top Cancer-Fighting Foods - Slideshow
• Viewer Comments: Lymphoma - Effective Treatment
• Viewer Comments: Lymphoma - Symptoms at Onset of Disease

Lymphoma (Hodgkin's Disease and Non-Hodgkin's Lymphoma) Overview

Lymphoma is a type of cancer involving cells of the immune system, called lymphocytes. Just as cancer represents many different diseases, lymphoma represents many different cancers of lymphocytes -- about 35 different subtypes, in fact.

Lymphoma is a group of cancers that affect the cells that play a role in the immune system and primarily represents cells involved in the lymphatic system of the body.

• The lymphatic system is part of the immune system. It consists of a network of vessels that carry a fluid called lymph, similar to the way that the network of blood vessels carry blood throughout the body. Lymph contains white blood cells called lymphocytes. Lymphocytes attack a variety of infectious agents as well as many cells in the precancerous stages of development.



• Lymph nodes are small collections of lymph tissue that occur throughout the body. The lymphatic system involves lymphatic channels that connect thousands of lymph nodes scattered throughout the body. Lymph flows through the lymph nodes, as well as through other lymphatic tissues including the spleen, the tonsils, the bone marrow, and the thymus gland.



• These lymph nodes filter the lymph, which may carry bacteria, viruses, or other microbes. At infection sites, large numbers of these microbial organisms collect in the regional lymph nodes and produce the swelling and tenderness typical of a localized infection. These enlarged and occasionally confluent collections of lymph nodes (so-called lymphadenopathy) are often referred to as "swollen glands." In some areas of the body (such as the anterior part of the neck), they are often visible when swollen.

Lymphocytes recognize infectious organisms and abnormal cells and destroy them. There are two major subtypes of lymphocytes: B lymphocytes and T lymphocytes, also referred to as B cells and T cells.

• B lymphocytes produce antibodies (proteins that circulate through the blood and lymph and attach to infectious organisms and abnormal cells). Antibodies essentially alert other cells of the immune system to recognize and destroy these intruders, also known as pathogens (the process is known as humoral immunity).



• T cells, when activated, can kill pathogens directly. T cells also play a part in the mechanisms of immune system control, to prevent the system from inappropriate overactivity or underactivity (in the process of cell mediated immunity).



• After fighting off an invader, some of the B and T lymphocytes "remember" the invader and are prepared to fight it off if it returns.

Cancer occurs when normal cells undergo a transformation whereby they grow and multiply uncontrollably. Lymphoma is a malignant transformation of either B or T cells or their subtypes.

• As the abnormal cells multiply, they may collect in one or more lymph nodes or in other lymph tissues such as the spleen.



• As the cells continue to multiply, they form a mass often referred to as a tumor.



• Tumors often overwhelm surrounding tissues by invading their space, thereby depriving them of the necessary oxygen and nutrients needed to survive and function normally.



• In lymphoma, abnormal lymphocytes travel from one lymph node to the next, and sometimes to remote organs, via the lymphatic system.



• While lymphomas are often confined to lymph nodes and other lymphatic tissue, they can spread to other types of tissue almost anywhere in the body. Lymphoma development outside of lymphatic tissue is called extranodal disease.

Lymphomas fall into one of two major categories: Hodgkin's lymphoma (HL, previously called Hodgkin's disease) and all other lymphomas (non-Hodgkin's lymphomas or NHLs).

• These two types occur in the same places, may be associated with the same symptoms, and often have similar appearance on physical examination. However, they are readily distinguishable via microscopic examination.



• Hodgkin's disease develops from a specific abnormal B lymphocyte lineage. NHL may derive from either abnormal B or T cells and are distinguished by unique genetic markers.



• There are five subtypes of Hodgkin's disease and about 30 subtypes of non-Hodgkin's lymphoma.



• Because there are so many different subtypes of lymphoma, the classification of lymphomas is complicated (it includes both the microscopic appearance as well as genetic and molecular markers).



• Many of the NHL subtypes look similar, but they are functionally quite different and respond to different therapies with different probabilities of cure. HL subtypes are microscopically distinct, and typing is based upon the microscopic differences as well as extent of disease.

Lymphoma is the most common type of blood cancer in the United States. It is the seventh most common cancer in adults and the third most common in children. Non-Hodgkin's lymphoma is far more common than Hodgkin's lymphoma.

• In the United States, about 66,000 new cases of NHL and 8,500 new cases of HL were expected to be diagnosed in 2010, and the overall incidence is increasing each year.



• About 20,000 deaths due to NHL were expected in 2010 as well as 1,300 deaths due to HL, with the survival rate of all but the most advanced cases of HL greater than that of other lymphomas.



• Lymphoma can occur at any age, including childhood. Hodgkin's disease is most common in two age groups: young adults 16-34 years of age and in older people 55 years of age and older. Non-Hodgkin's lymphoma is more likely to occur in older people.